Intragenic suppression of an active site mutation in the human apurinic/apyrimidinic endonuclease

J Mol Biol. 1999 Mar 19;287(1):47-57. doi: 10.1006/jmbi.1999.2573.

Abstract

The apurinic/apyrimidinic endonucleases (APE) contain several highly conserved sequence motifs. The glutamic acid residue in a consensus motif, LQE96TK98 in human APE (hAPE-1), is crucial because of its role in coordinating Mg2+, an essential cofactor. Random mutagenesis of the inactive E96A mutant cDNA, followed by phenotypic screening in Escherichia coli, led to isolation of an intragenic suppressor with a second site mutation, K98R. Although the Km of the suppressor mutant was about sixfold higher than that of the wild-type enzyme, their kcat values were similar for AP endonuclease activity. These results suggest that the E96A mutation affects only the DNA-binding step, but not the catalytic step of the enzyme. The 3' DNA phosphoesterase activities of the wild-type and the suppressor mutant were also comparable. No global change of the protein conformation is induced by the single or double mutations, but a local perturbation in the structural environment of tryptophan residues may be induced by the K98R mutation. The wild-type and suppressor mutant proteins have similar Mg2+ requirement for activity. These results suggest a minor perturbation in conformation of the suppressor mutant enabling an unidentified Asp or Glu residue to substitute for Glu96 in positioning Mg2+ during catalysis. The possibility that Asp70 is such a residue, based on its observed proximity to the metal-binding site in the wild-type protein, was excluded by site-specific mutation studies. It thus appears that another acidic residue coordinates with Mg2+ in the mutant protein. These results suggest a rather flexible conformation of the region surrounding the metal binding site in hAPE-1 which is not obvious from the X-ray crystallographic structure.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Carbon-Oxygen Lyases / chemistry
  • Carbon-Oxygen Lyases / drug effects
  • Carbon-Oxygen Lyases / genetics*
  • Carbon-Oxygen Lyases / metabolism
  • Catalytic Domain / genetics*
  • Cations, Divalent / pharmacology
  • DNA-(Apurinic or Apyrimidinic Site) Lyase
  • Deoxyribonuclease IV (Phage T4-Induced)
  • Escherichia coli / genetics
  • Escherichia coli Proteins*
  • Humans
  • Magnesium / pharmacology
  • Mutagenesis, Site-Directed
  • Mutation, Missense*
  • Protein Structure, Secondary
  • Recombinant Proteins
  • Suppression, Genetic*

Substances

  • Cations, Divalent
  • Escherichia coli Proteins
  • Recombinant Proteins
  • Deoxyribonuclease IV (Phage T4-Induced)
  • endonuclease IV, E coli
  • Carbon-Oxygen Lyases
  • DNA-(Apurinic or Apyrimidinic Site) Lyase
  • Magnesium